Summary & Overview
HCPCS S4015: Complete In Vitro Fertilization Cycle, Case Rate
HCPCS Level II code S4015 represents a bundled case rate for a complete in vitro fertilization (IVF) cycle. The code is used to denote a full-cycle IVF service, encompassing clinical evaluation, monitoring, procedures, and laboratory components when billed as a single case rate. This designation matters nationally as IVF case-rate billing affects coverage determinations, patient cost-sharing, and contracting between fertility providers and payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of where S4015 fits in reproductive medicine billing, expected sites of service, and common clinical contexts for use. The publication outlines benchmarking topics typically associated with case-rate IVF codes, relevant policy considerations for coverage and claims adjudication, and clinical context that clarifies what a complete cycle entails.
The material provides concise reference information for payers and provider billing teams: the code definition, service type, typical site of service, and gaps in available input data. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code S4015 describes a complete in vitro fertilization cycle, not otherwise specified, case rate. This code represents a bundled payment for the full set of services that comprise an in vitro fertilization (IVF) cycle when billed as a case rate.
-
Service type: Reproductive endocrinology and assisted reproductive technology service encompassing a full IVF cycle
-
Typical site of service: Fertility clinic or outpatient reproductive medicine center
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 34-year-old patient with a 3-year history of infertility presents to a fertility clinic for a complete in vitro fertilization (IVF) cycle billed under S4015. The patient has failed prior intrauterine insemination attempts and has a diagnosis of tubal factor infertility and diminished ovarian reserve. The clinical workflow begins with initial consultation and baseline testing (hormone levels, infectious disease screening, and ultrasound), proceeds to ovarian stimulation with monitored injectable gonadotropins, frequent transvaginal ultrasounds and serum estradiol monitoring, final oocyte maturation trigger, transvaginal oocyte retrieval under monitored anesthesia care, laboratory fertilization (conventional IVF or ICSI as indicated), embryo culture and grading, cryopreservation or fresh embryo transfer, and post-procedure luteal support and follow-up. The episode of care encompassed by S4015 is a comprehensive case rate intended to represent the complete IVF cycle including clinical visits, stimulation medications administration (when bundled), monitoring, operative retrieval, laboratory procedures, and immediate embryo transfer or cryopreservation as defined by the payer contract. Typical site of service is an ambulatory fertility center or hospital outpatient department with on-site embryology laboratory. Common patient counseling includes risks of ovarian hyperstimulation syndrome, procedural anesthesia risks, multiple gestation risk, and laboratory outcomes including fertilization and embryo quality monitoring.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|